Good Start Genetics®, Inc., an innovative molecular diagnostics company harnessing a powerful, proprietary next-generation DNA sequencing (NGS) capability, today announced that new data further supporting their robust platform validation and the clinical value of the GoodStart SelectTM carrier screening test will be presented during two poster sessions at the 2013 American Society for Reproductive Medicine Annual Meeting taking place October 12 – 17 in Boston.
Help employers find you! Check out all the jobs and post your resume.
